The proposed plan could better support doctors' ability to deliver precision cancer care by providing payment for services such as coordinating with pathologists and ordering the right test.

A genomics researcher from North Carolina State University outlined efforts to learn more about human cancers by studying dogs and other animals with spontaneous malignancies.

Researchers explored the predictive value of using mismatch repair deficiency and PD-L1 expression to assess which cancer patients are likely to respond to anti-PD-1 treatments.

Medicare Administrative Contractors didn't price codes describing whole-genome or exome sequencing, or cancer panels gauging 51 or more genes.

Researchers sequenced 25 Ebola genomes isolated from patients infected during the outbreak, publishing their results in Emerging Infectious Diseases. 

The suit alleges Bio-Rad fired its former general counsel for pursuing an investigation into bribery committed by the company's employees and agents in China. 

The firm plans to use the money for clinical trials to support reimbursement for and coverage of its TruGraf genomic transplant rejection test.

The loan amendment extends the deadline for drawing a $10 million tranche under the original loan agreement from June 30, 2015 to Dec. 31, 2015.

The effort has provided a comprehensive view of the toxin proteins involved in the sting of these dangerous jellyfish, which is now being used to identify targets for inhibitory drugs.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.

The company also restated its financial results for full-year 2014 and for the third quarter of 2014. 

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The multiplexed qPCR test can detect and differentiate four Dengue serotypes in a single reaction tube and is designed for both diagnosis and surveillance.

In the study, company researchers explored treating corn rootworms with RNAi molecules that would interfere with the viability of their offspring.

The UCSC Genome Bioinformatics group has released an updated genes track for the mouse genome browser. The release includes 63,244 total transcripts, compared with 61,642 in the previous version. Also, the total number of canonical genes has increased from 32,958 to 32,408. 

Transgenomic has launched its new CLIA laboratory-based test for EGFR mutation detection in cancer patients using proprietary MX-ICP technology with any sample type.

The test is for EGFR exon 20 T790M mutations that affect the utility of tyrosine kinase inhibitor drugs for non-small cell lung cancer and EGFR exon 12 S492R mutations that signify resistance to the widely-prescribed drug cetuximab in coloretal cancer patients. 

The test can use tissue, plasma, fine needle aspiration, bronchoscopy, cytology, and other bodily fluid samples. Actionable results will be available in seven to 10 working days, Transgenomic said.

Definiens has launched a suite of biomarker datafication services for oncology clinical development programs. These services will enable pharmaceutical and biotech companies gather comprehensive data from tissue samples that they can use to make decisions about which drug candidates to advance as well as assess the potential of companion diagnostics for patient stratification. Through the service, users gain access to data such as biomarker expression profiles, biological response to therapy and continuous biomarker readouts enabling advanced decision making and data analysis.

In Nature this week: genomic analysis of high-grade serous ovarian cancer, and more.

The new Riken president outlines some of his plans for the institute.

The partners will screen for molecules that could revive metabolic activity in heart tissue damaged by cardiovascular disease or failure.

The method, published in Nature Biotechnology this week, could work for other long-read data, such as from Oxford Nanopore's MinIon. 

The firms will use miRNA-based cell characterization workflows and technologies to develop panels for human MSC products and cell banks.